Product Description
SNU-182 cell line | EP-CL-0610 | Elabscience
Background: SNU-182 was derived in 1989 by J.-G.Park and associates from a primary hepatocellular carcinoma taken from a Korean patient prior to cytotoxic therapy.
Species: Homo sapiens, Human
Age: 24 years
Tissue: Liver
Morphology: Epithelial
Growth Properties: Adherent
Organism: Homo sapiens, Human
Species Cell: Human
application: N/A
Doubling Time: ~46 hours
Biosafety: 2
Subculturing: Remove and discard culture medium. Briefly rinse the cell layer with DPBS solution to remove all traces of serum that contains trypsin inhibitor. Add 1.0 to 2.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes). Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 4.0 to 6.0 mL of complete growth medium and aspirate cells by gently pipetting. Add appropriate aliquots of the cell suspension to new culture vessels.
Ratio: 1:3-1:6
Renewal: Every 2 to 3 days